PWM
DNA icon

Parkworth Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Parkworth Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$563 Sell
50
-125
-71% -$968 ﹤0.01% 608
2025
Q1 		$998 Buy
+175
New +$1.78K ﹤0.01% 260

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Parkworth Wealth Management's DNA Position: Q2 2025 in Review

Parkworth Wealth Management reduced its Ginkgo Bioworks (DNA) stake by 71% in Q2 2025, selling an estimated $968 and leaving 50 shares worth $563. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Parkworth Wealth Management first reported a position in DNA in Q1 2025 and has held it in 2 quarters since. The position peaked at $998 in Q1 2025. 165 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Parkworth Wealth Management held 50 shares of Ginkgo Bioworks worth $563 as of Q2 2025.
  • Parkworth Wealth Management sold 125 Ginkgo Bioworks shares in Q2 2025, an estimated $968.
  • Ginkgo Bioworks made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #608 holding.
  • Parkworth Wealth Management first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 2 quarters since.
  • Parkworth Wealth Management's Ginkgo Bioworks position peaked at $998 in Q1 2025.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.